Riltrava Aerosphere Unjoni Ewropea - Iżlandiż - EMA (European Medicines Agency)

riltrava aerosphere

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - lungnasjúkdómur, langvarandi hindrandi - lyf til veikindi öndunarvegi sjúkdómum, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.

Lunsumio Unjoni Ewropea - Iżlandiż - EMA (European Medicines Agency)

lunsumio

roche registration gmbh - mosunetuzumab - eitilæxli, follicular - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.

Dymista Nefúði, dreifa 137 míkróg / 50 míkróg/skammt Islanda - Iżlandiż - LYFJASTOFNUN (Icelandic Medicines Agency)

dymista nefúði, dreifa 137 míkróg / 50 míkróg/skammt

viatris aps - azelastinum hýdróklóríð; fluticasonum própíónat - nefúði, dreifa - 137 míkróg / 50 míkróg/skammt

Vigamox (Moxifloxacin Alcon) Augndropar, lausn 5 mg/ml Islanda - Iżlandiż - LYFJASTOFNUN (Icelandic Medicines Agency)

vigamox (moxifloxacin alcon) augndropar, lausn 5 mg/ml

novartis healthcare a/s - moxifloxacinum hýdróklóríð - augndropar, lausn - 5 mg/ml

Stamaril Stungulyfsstofn og leysir, dreifa Islanda - Iżlandiż - LYFJASTOFNUN (Icelandic Medicines Agency)

stamaril stungulyfsstofn og leysir, dreifa

sanofi pasteur* - gulusóttarveira 17d-204 stofn (lifandi, veikluð) - stungulyfsstofn og leysir, dreifa

Taptiqom sine (Taptiqom) Augndropar, lausn 15 microg/ml + 5 mg/ml Islanda - Iżlandiż - LYFJASTOFNUN (Icelandic Medicines Agency)

taptiqom sine (taptiqom) augndropar, lausn 15 microg/ml + 5 mg/ml

santen oy* - tafluprostum inn; timololum maleat - augndropar, lausn - 15 microg/ml + 5 mg/ml

Engerix B Stungulyf, dreifa Islanda - Iżlandiż - LYFJASTOFNUN (Icelandic Medicines Agency)

engerix b stungulyf, dreifa

glaxosmithkline pharma a/s - lifrarbólgu b yfirborðsmótefnavaki - stungulyf, dreifa